Sep 23, 2017
Starpharma rockets on cancer drug hope
The Herald Sun noted strong investor interest and support for Starpharma regarding its positive phase 1 DEP® docetaxel trial and that no neutropenia was reported in any patients.
This contains certain forward-looking statements.